Healthcare Experience

Brand Institute Healthcare Share of Market


Our Healthcare experience includes 609 clients, with 2421 partnered brands and 503 USAN/INN names. Below is our extensive portfolio, feel free to filter by clients, brands, category or USAN/INN Names.   ||  Click Here for Consumer/B2B Experience



CLIENTS BRANDS CATEGORY
OBAGI MEDICAL SOLUCLENZ Dermatology
OBAGI MEDICAL CLENZIDERM M.D. Dermatology
OBI PHARMA adagloxad simolenin Immunology
OCERA THERAPEUTICS ZYSA Gastrointestinal
OCTAPHARMA AB VIHUMA Hematology
OCTAPHARMA AB PANZYGA * Immunology
OCTAPHARMA AB NUWIQ * Hematology
OCTAPHARMA AB satoreotide Oncology
OCTREOPHARM satoreotide trizoxetan Oncology
OLATEC dapansutrile Pain & Inflammation
OLIVER-TOLAS HEALTHCARE PACKAGING OLIVER-TOLAS HEALTHCARE PACKAGING Corporate Identity
ONCOLOGY THERAPEUTICS NETWORK OTN - ONCOLOGY THERAPEUTICS NETWORK Corporate Identity
ONCOMED demcizumab Oncology
ONCOMED vantictumab Oncology
ONCOMED ipafricept Oncology
ONCOMED tarextumab Oncology
ONCOMED navicixizumab Oncology
ONCOMED rosmantuzumab Oncology
ONCOMED brontictuzumab Oncology
ONCOPEPTIDES melphalan flufenamide Oncology
ONCOTHERAPY SCIENCE latromotide Oncology
ONCOTHERAPY SCIENCE pradimotide Oncology
ONCOTHERAPY SCIENCE elpamotide Oncology
ONO ceralifimod immunology
OPEXA THERAPEUTICS imilecleucel-t Immunology
OPEXA THERAPEUTICS ABILI-T Clinical Trial Name
OPEXA THERAPEUTICS IMMPATH Technology Name
OPKO HEALTH RAYALDEE * Nephrology
OREXIGEN THERAPEUTICS CONTRAVE * Obesity
OREXO AB ZUBSOLV * Neurology
ORION PHARMA ARAMIS (ANDROGEN RECEPTOR INHIBITING AGENT FOR METASTATIC-FREE SURVIVAL Clinical Trial Name
ORION PHARMA COMTAN * Neurology
ORTHO DERMATOLOGICS RETIN-A MICRO PUMP Medical Device
ORTHO-MCNEIL PHARMACEUTICAL PANCREAZE Gastrointestinal
ORTHO-MCNEIL PHARMACEUTICAL DURAGESIC Pain & Inflammation
ORTHO-MCNEIL PHARMACEUTICAL RAZADYNE Neurology
ORTHO-MCNEIL PHARMACEUTICAL RAZADYNE ER Neurology
ORTHO-MCNEIL PHARMACEUTICAL TOPAMAX Neurology
ORTHOSENSOR ORTHOSENSOR Corporate Identity
ORTHOSENSOR VERASENSE Medical Device
OSI PHARMACEUTICALS linsitinib Oncology
OSI PHARMACEUTICALS GALACCTIC Clinical Trial Name
OSI PHARMACEUTICALS TARCEVA * Oncology
OSMOTICA PHARMACEUTICAL VENALTA - Product Identity
OSSUR SYMBIONIC LEG Medical Device
OTICON ALTA Medical Device
OTICON NERA Medical Device
OTSUKA PHARMACEUTICAL DELTYBA Antibiotic
OTSUKA PHARMACEUTICAL ABILIFY MAINTENA * Neurology
OTSUKA PHARMACEUTICAL brexpiprazole Neurology
OTSUKA PHARMACEUTICAL tolvaptan Nephrology
OTSUKA PHARMACEUTICAL REXULTI * Neurology
OTSUKA PHARMACEUTICAL JINARC * Nephrology
OTSUKA PHARMACEUTICAL ORALTAG * Medical Device
OTSUKA PHARMACEUTICAL MIKELUNA Ophthalmology
OTTOBOCK AGILIUM FREESTEP Medical Device
OVATION PHARMACEUTICALS SABRIL * Neurology
OWP PHARMACEUTICALS ROWEEPRA Neurology
OXIGENE fosbretabulin Oncology
OXIGENE fosbretabulin disodium Oncology
OXIGENE fosbretabulin tromethamine Oncology


* Denotes a comprehensive report of the safety regulatory research prepared by BI/DSI for submission of this name candidate to FDA and/or EMA, and/or Health Canada, and other Regulatory Agencies.

Back to top